Original Research
Accepted on 21 Nov 2024
Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasms
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 21 Nov 2024
in Cancer Immunity and Immunotherapy
Review
Accepted on 21 Nov 2024
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Accepted on 21 Nov 2024
in Cancer Immunity and Immunotherapy
Review
Accepted on 21 Nov 2024
in Nutritional Immunology
Original Research
Accepted on 21 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 21 Nov 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 21 Nov 2024
in T Cell Biology
Original Research
Accepted on 21 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 21 Nov 2024
in Cancer Immunity and Immunotherapy
Opinion
Accepted on 21 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 21 Nov 2024
in Cancer Immunity and Immunotherapy
Review
Accepted on 21 Nov 2024
in Inflammation
Original Research
Accepted on 21 Nov 2024
in Inflammation
Original Research
Accepted on 21 Nov 2024
in Cancer Immunity and Immunotherapy
Case Report
Published on 21 Nov 2024
in Microbial Immunology
Original Research
Published on 21 Nov 2024
in Inflammation